TIL sentiment intelligence

Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks

Tone

Neutral 50/100

Event

Earnings

Published

16 Jul 2026 18:49

Source

Market source

Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks

Tone

Neutral 50/100

Event

Earnings

Published

13 Jul 2026 12:30

Source

Market source

Avoiding Lag: Real-Time Signals in (TIL) Movement

This article analyzes Instil Bio Inc. (NYSE: TIL) using AI models to provide real-time trading signals and strategies. It identifies stable neutral readings in shorter horizons potentially easing long-term weak bias and notes compelling upside potential with no resistance levels

Tone

Neutral 50/100

Event

Market update

Published

11 Jul 2026 16:44

Source

Stock Traders Daily

Price to book forward of Instil Bio, Inc. – NASDAQ:TIL

This article focuses solely on the "Price to book forward" metric for Instil Bio, Inc. (NASDAQ: TIL). The content indicates no specific value, change, or percentage change for this financial metric, stating "No trades" and "Market closed" in the overview section. The page appears

Tone

Neutral 50/100

Event

Market update

Published

03 Jul 2026 09:40

Source

TradingView

Enterprise value to EBIT forward of Instil Bio, Inc. – NASDAQ:TIL

This page provides financial information for Instil Bio, Inc. (NASDAQ: TIL) on TradingView, specifically focusing on its enterprise value to EBIT forward. The content is primarily a data placeholder within the financial section for the company on the platform.

Tone

Neutral 50/100

Event

Market update

Published

30 Jun 2026 04:40

Source

TradingView

Price to sales forward of Instil Bio, Inc. – NASDAQ:TIL

This article provides the "Price to sales forward" value for Instil Bio, Inc. (NASDAQ: TIL) as listed on TradingView. It appears to be a financial data point without further analysis or context within the presented content. The article indicates the market was closed and no trade

Tone

Neutral 50/100

Event

Market update

Published

29 Jun 2026 12:11

Source

TradingView

5GT0 Forecast — Price Target — Prediction for 2027

This article provides a forecast for Instil Bio, Inc. (5GT0) stock, including a 1-year price target of 6.02 EUR based on one analyst's opinion. It also covers financial details such as past earnings, net income, upcoming earnings dates, and historical stock prices. The Q&A sectio

Tone

Neutral 50/100

Event

Earnings

Published

26 Jun 2026 07:11

Source

TradingView

Instil Bio Inc (TIL) Valuation: PE, PB & Fair Value Analysis

Instil Bio Inc (TIL) currently has a valuation score of 8.27, placing it 154th out of 389 companies in the Biotechnology & Medical Research industry. Its P/E ratio is -1.07, significantly below its recent high but above its recent low. The company has not yet disclosed relevant d

Tone

Neutral 50/100

Event

Market update

Published

18 Jun 2026 13:41

Source

TradingKey

Instil Bio Inc (TIL) Institutional Confidence

Instil Bio Inc (TIL) has an institutional shareholding score of 5.00, ranking 133rd in the Biotechnology & Medical Research industry. The institutional shareholding proportion is 67.86%, showing a quarter-over-quarter decrease of 0.00%. James Simons is the largest institutional s

Tone

Neutral 50/100

Event

Market update

Published

17 Jun 2026 21:09

Source

TradingKey

Instil Bio Inc (TIL) Financial Health: Profitability & Balance Sheet Analysis

Instil Bio Inc (TIL) has a current financial score of 6.26, ranking 269 out of 388 in the Biotechnology & Medical Research industry, indicating stable financial health but low operating efficiency. The analysis highlights that several key financial data points for categories like

Tone

Neutral 50/100

Event

Market update

Published

17 Jun 2026 21:09

Source

TradingKey

Instil Bio Inc (TIL) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Instil Bio Inc (TIL)'s dividend history and stock split events. It indicates that the company has not distributed any dividends over the past five years. The article also lists several stock split events, all described as "Merger 20→1" that oc

Tone

Neutral 50/100

Event

Deals and strategy

Published

17 Jun 2026 08:40

Source

TradingKey

Instil Bio (NASDAQ: TIL) director receives grant of 6,500 stock options

Instil Bio director George Matcham has been granted 6,500 stock options with an exercise price of $7.93 per share. These options will vest in 12 equal monthly installments beginning July 11, 2026, contingent on his continuous service. Unvested portions will fully vest at the next

Tone

Neutral 50/100

Event

Market update

Published

12 Jun 2026 18:39

Source

Stock Titan

Instil Bio (TIL) director Gwendolyn Binder awarded 6,500 stock options at $7.93

Instil Bio, Inc. Director Gwendolyn Binder has been awarded 6,500 stock options with an exercise price of $7.93 per share. These options are compensation, not a direct purchase, and will vest in 12 monthly installments starting July 11, 2026, contingent on her continuous service.

Tone

Neutral 50/100

Event

Market update

Published

12 Jun 2026 18:39

Source

Stock Titan

Instil Bio (TIL) director awarded 6,500 stock options at $7.93 strike

Instil Bio director Neil W. Gibson has been granted 6,500 stock options with an exercise price of $7.93 per share, expiring on June 10, 2036. The options will vest in 12 monthly installments starting July 11, 2026, subject to Gibson's continuous service. This grant is a compensat

Tone

Neutral 50/100

Event

Market update

Published

12 Jun 2026 18:39

Source

Stock Titan

Instil Bio (TIL) director awarded stock options for 6,500 shares at $7.93

Instil Bio director R. Kent McGaughy Jr. received a stock option grant for 6,500 shares at an exercise price of $7.93 per share. These options will vest in 12 equal monthly installments starting July 11, 2026, contingent on his continuous service, with full vesting upon certain e

Tone

Neutral 50/100

Event

Market update

Published

12 Jun 2026 04:10

Source

Stock Titan

[8-K] Instil Bio, Inc. Reports Material Event

Instil Bio, Inc. announced the results of its 2026 Annual Meeting of Stockholders. Shareholders elected George Matcham and Neil Gibson as Class II directors and ratified RSM US LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

Tone

Neutral 50/100

Event

Earnings

Published

11 Jun 2026 20:10

Source

Stock Titan

(TIL) Movement Within Algorithmic Entry Frameworks

This article analyzes Instil Bio Inc. (NYSE: TIL) through algorithmic entry frameworks, noting stable neutral readings in shorter horizons and potential easing of a long-term weak bias. No clear price positioning signal is identified, but the absence of resistance levels above th

Tone

Neutral 50/100

Event

Market update

Published

08 Jun 2026 13:16

Source

Stock Traders Daily

TIL - Instil Bio Inc Stock Price and Quote

This article provides a detailed overview of Instil Bio Inc (TIL) stock, including its current price, financial metrics, performance indicators, analyst ratings, and recent news. It highlights the company's financial state, insider transactions, and clinical development updates r

Tone

Neutral 50/100

Event

Analyst action

Published

30 May 2026 18:40

Source

Finviz

Instil Bio Releases Q1 2026 Financial Results

Instil Bio, Inc. reported a non-GAAP loss per share of $0.32 and a net loss of $2.2 million for the first quarter of 2026. Despite the loss, common for developing biopharmaceutical firms, Wall Street analysts maintain a positive outlook with consensus ratings reflecting confidenc

Tone

Neutral 50/100

Event

Earnings

Published

15 May 2026 12:40

Source

AlphaStreet